MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma
2020 · Blood · 56 citations
https://doi.org/10.1182/blood.2020005795
P
Pan Su
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
483
Citations
11
h-index
11
i10-index
Pan Su is an academic researcher. The author has contributed to research in topics: Nerve injury and regeneration & Neuroinflammation and Neurodegeneration Mechanisms & Tryptophan and brain disorders. The author has an h-index of 11, co-authored 24 publications.
ORCID: 0000-0002-7133-1777Papers by this author
worksEscape steering by cholecystokinin peptidergic signaling
2022 · Cell Reports · 26 citations
https://doi.org/10.1016/j.celrep.2022.110330
Sensory plasticity caused by up-down regulation encodes the information of short-term learning and memory
2025 · iScience · 5 citations
https://doi.org/10.1016/j.isci.2025.112215
NPC1 as a novel therapeutic target for induction of pyroptosis in cancers
2025 · Biomarker Research · 1 citations
https://doi.org/10.1186/s40364-025-00823-w
An Efficient Adjoint-Free Melnikov–Lyapunov Diagnostic for Transition Detection in Slow–Fast Chemical Reaction Networks
2026 · SSRN Electronic Journal · 0 citations
https://doi.org/10.2139/ssrn.6275667
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat